ABBOTT INDIA Financial Statement Analysis
|
||
The Revenues of ABBOTT INDIA have increased by 8.86% YoY .
The Earnings Per Share (EPS) of ABBOTT INDIA has increased by 18.87 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ABBOTT INDIA Last 5 Annual Financial Results
[BOM: 500488|NSE : ABBOTINDIA]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr | ₹4,093 Cr | ₹3,679 Cr |
Expenses | ₹4,143 Cr | ₹3,832 Cr | ₹3,391 Cr | ₹3,337 Cr | ₹3,075 Cr |
Operating Profit (Excl OI) | ₹1,205 Cr | ₹1,082 Cr | ₹919 Cr | ₹756 Cr | ₹604 Cr |
Other Income | ₹154 Cr | ₹83 Cr | ₹83 Cr | ₹115 Cr | ₹114 Cr |
Interest | ₹16 Cr | ₹19 Cr | ₹18 Cr | ₹8.53 Cr | ₹2.25 Cr |
Depreciation | ₹70 Cr | ₹66 Cr | ₹58 Cr | ₹60 Cr | ₹17 Cr |
Profit Before Tax | ₹1,274 Cr | ₹1,080 Cr | ₹926 Cr | ₹803 Cr | ₹699 Cr |
Profit After Tax | ₹949 Cr | ₹799 Cr | ₹691 Cr | ₹593 Cr | ₹450 Cr |
Consolidated Net Profit | ₹949 Cr | ₹799 Cr | ₹691 Cr | ₹593 Cr | ₹450 Cr |
Earnings Per Share (Rs) | ₹446.78 | ₹375.86 | ₹325.03 | ₹279.03 | ₹211.93 |
PAT Margin (%) | 17.29 | 15.89 | 15.45 | 14.49 | 12.24 |
ROE(%) | 32.07 | 29.95 | 27.89 | 27.09 | 24.66 |
ROCE(%) | 42.93 | 40.53 | 37.52 | 36.54 | 37.88 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 54,833.4 Cr |
Revenue (TTM) | : | ₹ 5,753.4 Cr |
Net Profit(TTM) | : | ₹ 1,145.6 Cr |
EPS (TTM) | : | ₹ 540.4 |
P/E (TTM) | : | 47.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
ABBOTT INDIA | -1.5% | -4.5% | 13.9% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
ABBOTT INDIA Revenues
[BOM: 500488|NSE : ABBOTINDIA]
Y-o-Y | 8.86 % |
5 Yr CAGR | 9.81 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹5,349 Cr | 8.86 | |
Mar2022 | ₹4,913 Cr | 14.00 | |
Mar2021 | ₹4,310 Cr | 5.30 | |
Mar2020 | ₹4,093 Cr | 11.27 | |
Mar2019 | ₹3,679 Cr | - |
ABBOTT INDIA Operating Profit
[BOM: 500488|NSE : ABBOTINDIA]
Y-o-Y | 11.46 % |
5 Yr CAGR | 18.86 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1,205 Cr | 11.46 | |
Mar2022 | ₹1,082 Cr | 17.71 | |
Mar2021 | ₹919 Cr | 21.52 | |
Mar2020 | ₹756 Cr | 25.19 | |
Mar2019 | ₹604 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.41 % |
5 Yr CAGR | 8.24 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 22.54% | 2.41 | |
Mar2022 | 22.01% | 3.24 | |
Mar2021 | 21.32% | 15.43 | |
Mar2020 | 18.47% | 12.48 | |
Mar2019 | 16.42% | - |
ABBOTT INDIA Profit After Tax
[BOM: 500488|NSE : ABBOTINDIA]
Y-o-Y | 18.87 % |
5 Yr CAGR | 20.50 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹949 Cr | 18.87 | |
Mar2022 | ₹799 Cr | 15.64 | |
Mar2021 | ₹691 Cr | 16.49 | |
Mar2020 | ₹593 Cr | 31.67 | |
Mar2019 | ₹450 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 8.81 % |
5 Yr CAGR | 9.02 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 17.29 % | 8.81 | |
Mar2022 | 15.89 % | 2.85 | |
Mar2021 | 15.45 % | 6.63 | |
Mar2020 | 14.49 % | 18.38 | |
Mar2019 | 12.24 % | - |
ABBOTT INDIA Earnings Per Share (EPS)
[BOM: 500488|NSE : ABBOTINDIA]
Y-o-Y | 18.87 % |
5 Yr CAGR | 20.50 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹447 | 18.87 | |
Mar2022 | ₹376 | 15.64 | |
Mar2021 | ₹325 | 16.49 | |
Mar2020 | ₹279 | 31.66 | |
Mar2019 | ₹212 | - |
ABBOTT INDIA Return on Capital Employed (ROCE)
[BOM: 500488|NSE : ABBOTINDIA]
Y-o-Y | 5.92 % |
5 Yr CAGR | 3.18 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 42.93% | 5.92 | |
Mar2022 | 40.53% | 8.02 | |
Mar2021 | 37.52% | 2.68 | |
Mar2020 | 36.54% | -3.54 | |
Mar2019 | 37.88% | - |
ABBOTT INDIA Share Price vs Sensex
Current Share Price | : | ₹25,864.8 |
Current MarketCap | : | ₹ 54,833.4 Cr |
Updated EOD on | : | Apr 26,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -1.5% |
-4.5% |
13.9% |
SENSEX | 0.9% |
1.5% |
23.6% |
ABBOTT INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | 4% | 9.7% | 67.3% |
S&P BSE MID CAP | 4% | 7.6% | 67.4% |
S&P BSE 400 MIDSMALLCAP | 3.8% | 9.1% | 62% |
S&P BSE 150 MIDCAP | 3.6% | 7.7% | 59.6% |
S&P BSE HEALTHCARE | 3% | 4% | 55.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 3.9% | 9.6% | 64.8% |
NIFTY MIDCAP150 | 3.7% | 8% | 60.4% |
NIFTY HEALTHCARE | 3.2% | 2.5% | 51.3% |
NIFTY PHARMA | 3.2% | 2.2% | 51.4% |
NIFTY500 MULTICAP 50:25:25 | 2.8% | 6.7% | 49.4% |
You may also like the below Video Courses
FAQ about ABBOTT INDIA Financials
How the annual revenues of ABBOTT INDIA have changed ?
The Revenues of ABBOTT INDIA have increased by 8.86% YoY .
How the Earnings per Share (EPS) of ABBOTT INDIA have changed?
The Earnings Per Share (EPS) of ABBOTT INDIA has increased by 18.87 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs